Literature DB >> 31067105

Pharmacists in HIV Prevention: An Untapped Potential.

Julie E Myers1, Davida Farhat1, Adrian Guzman1, Vibhuti Arya1.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31067105      PMCID： PMC6507967          DOI： 10.2105/AJPH.2019.305057

Source DB:  PubMed          Journal:  Am J Public Health        ISSN： 0090-0036            Impact factor:   9.308


× No keyword cloud information.
  3 in total

1.  Implementation of a community pharmacy-based pre-exposure prophylaxis service: a novel model for pre-exposure prophylaxis care.

Authors:  Elyse L Tung; Annalisa Thomas; Allyson Eichner; Peter Shalit
Journal:  Sex Health       Date:  2018-11       Impact factor: 2.706

2.  Pharmacy-randomized intervention delivering HIV prevention services during the syringe sale to people who inject drugs in New York City.

Authors:  Crystal Fuller Lewis; Alexis V Rivera; Natalie D Crawford; Jennifer DeCuir; Silvia Amesty
Journal:  Drug Alcohol Depend       Date:  2015-06-10       Impact factor: 4.492

3.  Assessing the effectiveness of pharmacy-based adherence interventions on antiretroviral adherence in persons with HIV.

Authors:  Kevin C Henderson; Jason Hindman; Steven C Johnson; Robert J Valuck; Jennifer J Kiser
Journal:  AIDS Patient Care STDS       Date:  2011-02-16       Impact factor: 5.078
  3 in total
  12 in total

Review 1.  Pharmacy-Based Infectious Disease Management Programs Incorporating CLIA-Waived Point-of-Care Tests.

Authors:  S R Herbin; D G Klepser; M E Klepser
Journal:  J Clin Microbiol       Date:  2020-04-23       Impact factor: 5.948

2.  Pharmacy-based pre-exposure prophylaxis support among pharmacists and men who have sex with men.

Authors:  Natalie D Crawford; Dorie Josma; Joseph Morris; Roderick Hopkins; Henry N Young
Journal:  J Am Pharm Assoc (2003)       Date:  2020-01-30

3.  Examining the Multilevel Barriers to Pharmacy-Based HIV Prevention and Treatment Services.

Authors:  Natalie D Crawford; Crystal F Lewis; Ronnie Moore; Glen Pietradoni; Paul Weidle
Journal:  Sex Transm Dis       Date:  2022-05-12       Impact factor: 3.868

4.  Estimated effect of US state syringe sale policy on source of last-used injection equipment.

Authors:  Patrick Janulis; Barrett W Montgomery; James C Anthony
Journal:  Int J Drug Policy       Date:  2019-12-13

5.  The Role of Pharmacies in the HIV Prevention and Care Continuums: A Systematic Review.

Authors:  Natalie D Crawford; Sky Myers; Henry Young; Donald Klepser; Elyse Tung
Journal:  AIDS Behav       Date:  2021-01-02

6.  Knowledge of HIV and HIV pre-exposure prophylaxis among medical and pharmacy students: A national, multi-site, cross-sectional study.

Authors:  Samuel R Bunting; Brian A Feinstein; Aniruddha Hazra; Neeral K Sheth; Sarah S Garber
Journal:  Prev Med Rep       Date:  2021-10-07

Review 7.  Pharmacy-Based Interventions to Increase Use of HIV Pre-exposure Prophylaxis in the United States: A Scoping Review.

Authors:  Alice Zhao; Derek T Dangerfield; Amy Nunn; Rupa Patel; Jason E Farley; Chinenye C Ugoji; Lorraine T Dean
Journal:  AIDS Behav       Date:  2021-10-20

8.  PrEP distribution in pharmacies: a systematic review.

Authors:  Caitlin E Kennedy; Ping Teresa Yeh; Kaitlyn Atkins; Laura Ferguson; Rachel Baggaley; Manjulaa Narasimhan
Journal:  BMJ Open       Date:  2022-02-21       Impact factor: 3.006

9.  Community pharmacist engagement in HIV and HCV prevention: Current practices and potential for service uptake.

Authors:  KariLynn Dowling-McClay; Stephanie M Mathis; Nicholas Hagemeier
Journal:  Explor Res Clin Soc Pharm       Date:  2021-10-28

10.  Perspectives on preparing for long-acting injectable treatment for HIV among consumer, clinical and nonclinical stakeholders: A qualitative study exploring the anticipated challenges and opportunities for implementation in Los Angeles County.

Authors:  Oluwadamilola Jolayemi; Laura M Bogart; Erik D Storholm; David Goodman-Meza; Elena Rosenberg-Carlson; Rebecca Cohen; Uyen Kao; Steve Shoptaw; Raphael J Landovitz
Journal:  PLoS One       Date:  2022-02-03       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.